Biomaterials Forum Issues

Q4 2024 Forum Cover

Publications

2024 Q4 Biomaterials Forum is Available Now!

This issue includes a highlight of the celebration of the 50-year legacy of the Society at the 2025 Annual Meeting, as well as details of the recent US FDA approval of two new medical therapies, and the US DOJ's efforts to block UnitedHealth Group's proposed acquisition of Amedisys. Read more inside!

You must be a member to access the current issue.
Fourth Quarter 2024
Third Quarter 2024
Second Quarter 2024
First Quarter 2024
Fourth Quarter 2023
Third Quarter 2023
Second Quarter 2023
First Quarter 2023
Fourth Quarter 2022
Third Quarter 2022
Second Quarter 2022
First Quarter 2022
Fourth Quarter 2021
Third Quarter 2021
Second Quarter 2021
First Quarter 2021
Fourth Quarter 2020
Third Quarter 2020
Second Quarter 2020
First Quarter 2020